Levothroid and Zaroxolyn drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Levothroid (levothyroxine sodium) and Zaroxolyn (metolazone). Common drug interactions include drug ineffective among females and gastrointestinal haemorrhage among males.
The phase IV clinical study analyzes what interactions people have when they take Levothroid and Zaroxolyn. It is created by eHealthMe based on reports of 46 people who take the same drugs from the FDA, and is updated regularly.
What is Levothroid?
Levothroid has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 8,974 Levothroid users. Check the latest studies of Levothroid.
What is Zaroxolyn?
Zaroxolyn has active ingredients of metolazone. It is often used in high blood pressure. eHealthMe is studying from 5,244 Zaroxolyn users. Check the latest studies of Zaroxolyn.
46 people who take Levothroid and Zaroxolyn together, and have interactions are studied.

What are the common drug interactions of Levothroid and Zaroxolyn, by gender? *:
female:
- Drug ineffective
- Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
- Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
- Fatigue (feeling of tiredness)
- Feeling hot
- Fibromyalgia (a long-term condition which causes pain all over the body)
- Flushing (the warm, red condition of human skin)
- Formication (a sensation that exactly resembles that of small insects crawling on (or under) the skin)
- Generalised oedema (swelling all over the body)
- Glomerular filtration rate decreased
male:
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Blood alkaline phosphatase nos increased
- Pulmonary embolism (blockage of the main artery of the lung)
- Pulseless electrical activity
- Shock haemorrhagic (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin due to excess bleeding)
- Alanine aminotransferase increased
- Asthenia (weakness)
- Blood bilirubin increased
- Cardiac failure
- Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
What are the common drug interactions of Levothroid and Zaroxolyn, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Depressed mood
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Therapeutic response unexpected
50-59:
- Swelling
- Cold sweat
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Disorientation (disability in which the senses of time, direction, and recognition of people and places)
- Drug ineffective
- Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
- Formication (a sensation that exactly resembles that of small insects crawling on (or under) the skin)
- Heart disease
- Nausea (feeling of having an urge to vomit)
- Stomach discomfort (pain in abdomen)
60+:
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Dyspnoea (difficult or laboured respiration)
- Cough
- Death
- Decreased appetite
- Gamma-glutamyltransferase increased
- Haematoma (collection of blood outside the blood vessels)
- Hypotension (abnormally low blood pressure)
- Incoherent (talking in a confused and unclear way)
- Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
What are the existing conditions these people have? *
- Pain: 13 people, 28.26%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 13 people, 28.26%
- Dyspnea (difficult or laboured breathing): 7 people, 15.22%
- Type 2 Diabetes: 4 people, 8.70%
- Stress And Anxiety: 4 people, 8.70%
- Fever: 4 people, 8.70%
- Diabetes: 4 people, 8.70%
- Constipation: 4 people, 8.70%
- Rashes (redness): 3 people, 6.52%
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 6.52%
* Approximation only. Some reports may have incomplete information.
Do you take Levothroid and Zaroxolyn?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Levothroid (8,974 reports)
- Zaroxolyn (5,244 reports)
Browse all drug interactions of Levothroid and Zaroxolyn:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Levothroid:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Zaroxolyn:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Levothroid and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Zaroxolyn and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on levothyroxine sodium and metolazone (the active ingredients of Levothroid and Zaroxolyn, respectively), and Levothroid and Zaroxolyn (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Zegerid cause Osteoporosis? - a second ago
- Could Aromasin cause Hair Growth Abnormal? - 4 seconds ago
- Drug interactions of Vitamins and Velphoro - 7 seconds ago
- Could Decadron cause Acidosis? - 10 seconds ago
- Could Xanax cause Sarcoma? - 12 seconds ago
- Could Levocetirizine Dihydrochloride cause Rash Erythematous? - 14 seconds ago
- Drug interactions of Flolan and Revatio - 14 seconds ago
- Could Trisenox cause Dizziness? - 21 seconds ago
- Could Levaquin cause Sciatica Aggravated? - 33 seconds ago
- Could Sotret cause White Blood Cell Count Decreased? - 53 seconds ago